Cargando…
Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder
Disabled homolog-2 (DAB2) has been reported to be a tumor suppressor gene. However, a number of contrary studies suggested that DAB2 promotes tumor invasion in urothelial carcinoma of the bladder (UCB). Here, we investigated the clinical role and biological function of DAB2 in human UCB. Immunohisto...
Autores principales: | Itami, Yoshitaka, Miyake, Makito, Ohnishi, Sayuri, Tatsumi, Yoshihiro, Gotoh, Daisuke, Hori, Shunta, Morizawa, Yousuke, Iida, Kota, Ohnishi, Kenta, Nakai, Yasushi, Inoue, Takeshi, Anai, Satoshi, Tanaka, Nobumichi, Fujii, Tomomi, Shimada, Keiji, Furuya, Hideki, Khadka, Vedbar S., Deng, Youping, Fujimoto, Kiyohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168324/ https://www.ncbi.nlm.nih.gov/pubmed/31968685 http://dx.doi.org/10.3390/diagnostics10010054 |
Ejemplares similares
-
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder
por: Miyake, Makito, et al.
Publicado: (2017) -
Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
por: Miyake, Makito, et al.
Publicado: (2019) -
Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort
por: Miyake, Makito, et al.
Publicado: (2017) -
Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model
por: Miyake, Makito, et al.
Publicado: (2020) -
Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2019)